We further explored the expression of SPOCK2 in some tumors, including basal cell carcinoma (BCC), liver hepatocellular carcinoma (LIHC), prostate adenocarcinoma (PRAD), and squamous cell carcinoma (SCC). Here, SPOCK2 is linked to prostate adenocarcinoma.